Variables | Total (n = 167) | G1 (n = 49) | G2 (n = 69) | G3 (n = 49) | P |
---|---|---|---|---|---|
CDP-1, μg/mL | 1.56 ± 1.80 | 0.83 ± 0.78 | 1.29 ± 0.92 | 2.67 ± 2.73 | <0.001 |
CDP-1-m, μg/mL | 0.64 ± 0.64 | 0.38 ± 0.08 | 0.54 ± 0.07 | 1.01 ± 0.08 | <0.001 |
CDP-1-M, μg/mL | 0.93 ± 1.18 | 0.45 ± 0.15 | 0.74 ± 0.13 | 1.66 ± 1.36 | <0.001 |
Vancomycin (UPLC-MS/MS), μg/mL | 24.87 ± 16.06 | 18.48 ± 10.94 | 23.66 ± 11.95 | 32.63 ± 21.69 | <0.001 |
Vancomycin (CMIA), μg/mL | 27.80 ± 20.48 | 20.24 ± 12.97 | 25.63 ± 13.98 | 38.08 ± 28.63 | <0.001 |
VCMIA/VUPLC-MS/MS ratio | 1.09 ± 0.10 | 1.06 ± 0.08 | 1.08 ± 0.09 | 1.12 ± 0.12 | 0.008 |
C/VUPLC-MS/MS ratio, % | 5.65 ± 2.50 | 4.18 ± 1.40 | 5.12 ± 1.46 | 7.88 ± 3.10 | <0.001 |